Takeda Gets Actos Case Paused For Class Cert. Review
By Matthew Perlman · April 14, 2025, 3:55 PM EDT
A New York federal court has paused a lawsuit accusing Takeda Pharmaceuticals of inflating the price of its diabetes treatment, Actos, by delaying the entry of generic alternatives, and took a...
To view the full article, register now.